Caris Competitors
| CAI Stock | USD 21.84 1.36 5.86% |
Caris Life vs Rhythm Pharmaceuticals Correlation
Modest diversification
The correlation between Caris Life Sciences and RYTM is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Caris Life Sciences and RYTM in the same portfolio, assuming nothing else is changed.
Moving against Caris Stock
| 0.56 | MSM | MSC Industrial Direct | PairCorr |
| 0.36 | FERG | Ferguson Plc | PairCorr |
| 0.32 | WCC | WESCO International Earnings Call This Week | PairCorr |
Caris Life Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Caris Life and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Caris and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Caris Life Sciences does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Caris Stock performing well and Caris Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Caris Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| JAZZ | 1.69 | 0.32 | 0.13 | (0.44) | 1.68 | 3.66 | 25.96 | |||
| RNA | 0.17 | 0.05 | 0.10 | 0.95 | 0.00 | 0.38 | 1.75 | |||
| MRNA | 3.54 | 0.64 | 0.16 | 0.29 | 4.08 | 9.21 | 23.11 | |||
| CYTK | 2.15 | (0.09) | 0.00 | (0.07) | 0.00 | 4.25 | 10.86 | |||
| MDGL | 2.10 | 0.16 | 0.07 | 0.28 | 2.10 | 7.29 | 16.78 | |||
| HALO | 1.54 | 0.27 | 0.13 | 0.62 | 1.66 | 3.72 | 9.83 | |||
| ABVX | 3.15 | 0.21 | 0.05 | (0.87) | 3.55 | 6.94 | 29.38 | |||
| CORT | 3.69 | (0.71) | 0.00 | (0.23) | 0.00 | 6.49 | 58.23 | |||
| RYTM | 2.50 | (0.13) | 0.00 | (0.08) | 0.00 | 4.76 | 18.69 |
Cross Equities Net Income Analysis
Compare Caris Life Sciences and related stocks such as Jazz Pharmaceuticals PLC, Avidity Biosciences, and Moderna Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAZZ | (24.8 M) | 125 M | 288.6 M | 216.3 M | 58.4 M | 329.5 M | 396.8 M | 487.8 M | 447.1 M | 523.4 M | 238.6 M | (329 M) | (224.1 M) | 414.8 M | 560.1 M | 644.1 M | 676.3 M |
| RNA | (11.9 M) | (11.9 M) | (11.9 M) | (11.9 M) | (11.9 M) | (11.9 M) | (11.9 M) | (11.9 M) | (11.9 M) | (24.7 M) | (44 M) | (117.4 M) | (169.1 M) | (212.2 M) | (322.3 M) | (290.1 M) | (275.6 M) |
| MRNA | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (1.1 M) | (216.2 M) | (255.9 M) | (384.7 M) | (514 M) | (747.1 M) | 12.2 B | 8.4 B | (4.7 B) | (3.6 B) | (4.1 B) | (3.9 B) |
| CYTK | (13.1 M) | (47.9 M) | (41.7 M) | (33.7 M) | (14.6 M) | (37.5 M) | 16.5 M | (127.8 M) | (106.3 M) | (121.7 M) | (127.3 M) | (215.3 M) | (389 M) | (526.2 M) | (589.5 M) | (530.6 M) | (504 M) |
| MDGL | (381 K) | (47.4 M) | (62.8 M) | (90.2 M) | (86.2 M) | (6.8 M) | (26.4 M) | (31.2 M) | (32.8 M) | (72.8 M) | (197.4 M) | (241.1 M) | (295.4 M) | (373.6 M) | (465.9 M) | (419.3 M) | (398.3 M) |
| HALO | (39.7 K) | (19.8 M) | (53.6 M) | (83.5 M) | (68.4 M) | (32.2 M) | (103 M) | 63 M | (80.3 M) | (72.2 M) | 129.1 M | 402.7 M | 202.1 M | 281.6 M | 444.1 M | 510.7 M | 536.2 M |
| ABVX | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.1 M) | (16 M) | (14.3 M) | (11.2 M) | (15.8 M) | (30.6 M) | (37.6 M) | (42.5 M) | (60.7 M) | (147.7 M) | (176.2 M) | (158.6 M) | (150.7 M) |
| CORT | (7.5 M) | (32.4 M) | (38 M) | (46 M) | (31.4 M) | (6.4 M) | 8.1 M | 129.1 M | 75.4 M | 94.2 M | 106 M | 112.5 M | 101.4 M | 106.1 M | 139.7 M | 160.7 M | 168.7 M |
| RYTM | (18.1 M) | (18.1 M) | (18.1 M) | (21.4 M) | (6.5 M) | (11.1 M) | (25.9 M) | (33.7 M) | (74.1 M) | (134.6 M) | (130.7 M) | (68 M) | (181.1 M) | (184.7 M) | (260.6 M) | (234.5 M) | (222.8 M) |
Caris Life Sciences and related stocks such as Jazz Pharmaceuticals PLC, Avidity Biosciences, and Moderna Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Caris Life Sciences financial statement analysis. It represents the amount of money remaining after all of Caris Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Caris Life Competitive Analysis
The better you understand Caris Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Caris Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Caris Life's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Caris Life Competition Performance Charts
Five steps to successful analysis of Caris Life Competition
Caris Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Caris Life Sciences in relation to its competition. Caris Life's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Caris Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Caris Life's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Caris Life Sciences, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Caris Life position
In addition to having Caris Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Caris Life Correlation with its peers. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is there potential for Trading Companies & Distributors market expansion? Will Caris introduce new products? Factors like these will boost the valuation of Caris Life. Projected growth potential of Caris fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Caris Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Caris Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Caris Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.